Can group learning make biotherapy safer for arthritis patients?

NCT ID NCT03838939

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial investigates whether combining group and individual educational sessions helps patients with chronic inflammatory rheumatism (like rheumatoid arthritis or spondyloarthritis) learn safety skills better than individual sessions alone. Participants are starting their first subcutaneous biotherapy and will be randomly assigned to either individual education or individual plus group sessions. The study measures safety knowledge using a questionnaire at the start and after six months, focusing on recognizing warning signs and managing daily situations like infections or surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Therapeutic education sessions (individual and group)
What this could lead to
If group sessions boost safety skills, this could lead to better self-management and fewer complications for people on biotherapy.
What could go wrong
The trial is relatively small and measures knowledge rather than real-world outcomes, so benefits may not translate into fewer infections or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chu Clermont-Ferrand

    Clermont-Ferrand, 63003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.